Correlation Between Tempest Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Tempest Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Tempest Therapeutics and Lixte Biotechnology
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tempest and Lixte is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Lixte Biotechnology
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Lixte Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 2.96 times less risky than Lixte Biotechnology. The stock trades about -0.15 of its potential returns per unit of risk. The Lixte Biotechnology Holdings is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Lixte Biotechnology Holdings on August 26, 2024 and sell it today you would earn a total of 3.00 from holding Lixte Biotechnology Holdings or generate 1.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Tempest Therapeutics |
| Lixte Biotechnology |
Tempest Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Tempest Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Neurobo Pharmaceuticals | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |